{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T08:07:33Z","timestamp":1773302853668,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T00:00:00Z","timestamp":1595808000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T00:00:00Z","timestamp":1595808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Neurovirol."],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s13365-020-00884-7","type":"journal-article","created":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T18:05:51Z","timestamp":1595873151000},"page":"797-799","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Severe rapidly progressive Guillain-Barr\u00e9 syndrome in the setting of acute COVID-19 disease"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9675-4012","authenticated-orcid":false,"given":"Rory M.C.","family":"Abrams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian D.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desiree M.","family":"Markantone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaitlin","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto E.","family":"Paniz-Mondolfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa R.","family":"Gitman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Yoon","family":"Choo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winona","family":"Tse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Robinson-Papp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,27]]},"reference":[{"issue":"6","key":"884_CR1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/NRL.0000000000000197","volume":"23","author":"RMC Abrams","year":"2018","unstructured":"Abrams RMC, Elder GA (2018) Safety of therapeutic plasma exchange for the treatment of Guillain-Barre syndrome in polycythemia vera. Neurologist. 23(6):185\u2013187","journal-title":"Neurologist."},{"key":"884_CR2","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1016\/j.jacc.2020.04.031","volume":"75","author":"B Bikdeli","year":"2020","unstructured":"Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, Nigoghossian C, Ageno W, Madjid M, Guo Y, Tang LV, Hu Y, Giri J, Cushman M, Qu\u00e9r\u00e9 I, Dimakakos EP, Gibson CM, Lippi G, Favaloro EJ, Fareed J, Caprini JA, Tafur AJ, Burton JR, Francese DP, Wang EY, Falanga A, McLintock C, Hunt BJ, Spyropoulos AC, Barnes GD, Eikelboom JW, Weinberg I, Schulman S, Carrier M, Piazza G, Beckman JA, Steg PG, Stone GW, Rosenkranz S, Goldhaber SZ, Parikh SA, Monreal M, Krumholz HM, Konstantinides SV, Weitz JI, Lip GYH, Global COVID-19 Thrombosis Collaborative Group, Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function (2020) COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up. J Am Coll Cardiol 75:2950\u20132973","journal-title":"J Am Coll Cardiol"},{"key":"884_CR3","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/bs.pmbts.2014.12.002","volume":"131","author":"JC Fehrenbacher","year":"2015","unstructured":"Fehrenbacher JC (2015) Chemotherapy-induced peripheral neuropathy. Prog Mol Biol Transl Sci 131:471\u2013508","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"Pt 1","key":"884_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/brain\/awt285","volume":"137","author":"C Fokke","year":"2014","unstructured":"Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn PA, Jacobs BC (2014) Diagnosis of Guillain-Barre syndrome and validation of Brighton criteria. Brain. 137(Pt 1):33\u201343","journal-title":"Brain."},{"key":"884_CR5","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1212\/WNL.0000000000009566","volume":"94","author":"AC Guidon","year":"2020","unstructured":"Guidon AC, Amato AA (2020) COVID-19 and neuromuscular disorders. Neurology. 94:959\u2013969","journal-title":"Neurology."},{"key":"884_CR6","doi-asserted-by":"publisher","unstructured":"Gutierrez-Ortiz C, Mendez A, Rodrigo-Rey S, San Pedro-Murillo E, Bermejo-Guerrero L, Gordo-Manas R et al (2020) Miller fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000009619","DOI":"10.1212\/WNL.0000000000009619"},{"issue":"9","key":"884_CR7","first-page":"OD16","volume":"11","author":"J James","year":"2017","unstructured":"James J, Jose J (2017) Syndrome of inappropriate secretion of antidiuretic hormone preceding Guillain-Barre syndrome. J Clin Diagn Res 11(9):OD16\u2013OD17","journal-title":"J Clin Diagn Res"},{"issue":"4","key":"884_CR8","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/ana.24755","volume":"80","author":"PM Meyer Sauteur","year":"2016","unstructured":"Meyer Sauteur PM, Huizinga R, Tio-Gillen AP, Roodbol J, Hoogenboezem T, Jacobs E, van Rijn M, van der Eijk AA, Vink C, de Wit MCY, van Rossum AMC, Jacobs BC (2016) Mycoplasma pneumoniae triggering the Guillain-Barre syndrome: a case-control study. Ann Neurol 80(4):566\u2013580","journal-title":"Ann Neurol"},{"issue":"7","key":"884_CR9","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1007\/s00415-020-09849-6","volume":"267","author":"M Padroni","year":"2020","unstructured":"Padroni M, Mastrangelo V, Asioli GM, Pavolucci L, Abu-Rumeileh S, Piscaglia MG et al (2020) Guillain-Barre syndrome following COVID-19: new infection, old complication? J Neurol 267(7):1877\u20131879","journal-title":"J Neurol"},{"key":"884_CR10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jocn.2020.04.062","volume":"76","author":"Z Sedaghat","year":"2020","unstructured":"Sedaghat Z, Karimi N (2020) Guillain Barre syndrome associated with COVID-19 infection: a case report. J Clin Neurosci 76:233\u2013235","journal-title":"J Clin Neurosci"},{"issue":"2","key":"884_CR11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/ajh.10325","volume":"73","author":"BA Steinberger","year":"2003","unstructured":"Steinberger BA, Ford SM, Coleman TA (2003) Intravenous immunoglobulin therapy results in post-infusional hyperproteinemia, increased serum viscosity, and pseudohyponatremia. Am J Hematol 73(2):97\u2013100","journal-title":"Am J Hematol"},{"key":"884_CR12","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1002\/ajh.25829","volume":"95","author":"E Terpos","year":"2020","unstructured":"Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, Psaltopoulou T, Gerotziafas G, Dimopoulos MA (2020) Hematological findings and complications of COVID-19. Am J Hematol 95:834\u2013847","journal-title":"Am J Hematol"},{"key":"884_CR13","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1056\/NEJMc2009191","volume":"382","author":"G Toscano","year":"2020","unstructured":"Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG, Franciotta D, Baldanti F, Daturi R, Postorino P, Cavallini A, Micieli G (2020) Guillain-Barre syndrome associated with SARS-CoV-2. N Engl J Med 382:2574\u20132576","journal-title":"N Engl J Med"},{"issue":"3","key":"884_CR14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.mayocp.2016.12.002","volume":"92","author":"EF Wijdicks","year":"2017","unstructured":"Wijdicks EF, Klein CJ (2017) Guillain-Barre syndrome. Mayo Clin Proc 92(3):467\u2013479","journal-title":"Mayo Clin Proc"},{"key":"884_CR15","doi-asserted-by":"publisher","first-page":"104358","DOI":"10.1016\/j.jcv.2020.104358","volume":"127","author":"Q Zhao","year":"2020","unstructured":"Zhao Q, He Y (2020) Challenges of convalescent plasma therapy on COVID-19. J Clin Virol 127:104358","journal-title":"J Clin Virol"},{"issue":"5","key":"884_CR16","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S1474-4422(20)30109-5","volume":"19","author":"H Zhao","year":"2020","unstructured":"Zhao H, Shen D, Zhou H, Liu J, Chen S (2020) Guillain-Barre syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol 19(5):383\u2013384","journal-title":"Lancet Neurol"}],"container-title":["Journal of NeuroVirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-020-00884-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13365-020-00884-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-020-00884-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T00:18:34Z","timestamp":1627345114000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13365-020-00884-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,27]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["884"],"URL":"https:\/\/doi.org\/10.1007\/s13365-020-00884-7","relation":{},"ISSN":["1355-0284","1538-2443"],"issn-type":[{"value":"1355-0284","type":"print"},{"value":"1538-2443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,27]]},"assertion":[{"value":"7 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}